Schizophrenia Research
Volume 112, Issue 1 , Pages 65-71 , July 2009

Regional and duration of illness differences in the alteration of NCAM-180 mRNA expression within the cortex of subjects with schizophrenia

  • A.S. Gibbons

      Affiliations

    • Rebecca L. Cooper Research Laboratories, Mental Health Research Institute of Victoria, Parkville, Victoria, Australia
    • Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia
    • Corresponding Author InformationCorresponding author. The Rebecca L. Cooper Research Laboratories, The Mental Health Research Institute of Victoria, Locked Bag 11, Parkville, VIC 3052, Australia. Tel.: +61 3 9389 2995; fax: +61 3 9387 5061.
    • ,
  • E.A. Thomas

      Affiliations

    • Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA
    • ,
  • B. Dean

      Affiliations

    • Rebecca L. Cooper Research Laboratories, Mental Health Research Institute of Victoria, Parkville, Victoria, Australia
    • Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia
    • Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia
    • Department of Psychological Medicine, Monash University, Clayton, Victoria, Australia

Received 11 December 2008 ,Revised 31 March 2009 ,Accepted 2 April 2009.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Association; 1994;
  2. Arai M, Yamada K, Toyota T, Obata N, Haga S, Yoshida Y, et al. Association between polymorphisms in the promoter region of the sialyltransferase 8B (SIAT8B) gene and schizophrenia. Biol. Psychiatry. 2006;59:652–659
  3. Atz ME, Rollins B, Vawter MP. NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences. Psychiatr. Genet. 2007;17:55–67
  4. Barbas JA, Chaix JC, Steinmetz M, Goridis C. Differential splicing and alternative polyadenylation generates distinct NCAM transcripts and proteins in the mouse. EMBO J. 1988;7:625–632
  5. Barbeau D, Liang JJ, Robitaille Y, Quirion R, Srivastava LK. Decreased expression of the embryonic form of the neural cell-adhesion molecule in schizophrenic brains. PNAS USA. 1995;92:2785–2789
  6. Burgess PW, Dumontheil I, Gilbert SJ. The gateway hypothesis of rostral prefrontal cortex (area 10) function. Trends Cogn. Sci. 2007;11:290–298
  7. Buttner B, Reutter W, Horstkorte R. Cytoplasmic domain of NCAM 180 reduces NCAM-mediated neurite outgrowth. J. Neurosci. Res. 2004;75:854–860
  8. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal. Biochem. 1987;162:156–159
  9. Cremer H, Lange R, Christoph A, Plomann M, Vopper G, Roes J, et al. Inactivation of the N-CAM gene in mice results in size-reduction of the olfactory-bulb and deficits in spatial-learning. Nature. 1994;367:455–459
  10. Cremer H, Chazal G, Goridis C, Represa A. NCAM is essential for axonal growth and fasciculation in the hippocampus. Mol. Cell. Neurosci. 1997;8:323–335
  11. D'Esposito M, Aguirre GK, Zarahn E, Ballard D, Shin RK, Lease J. Functional MRI studies of spatial and nonspatial working memory. Brain Res. Cogn. Brain Res. 1998;7:1–13
  12. Dean B, Keriakous D, Scarr E, Thomas EA. Gene expression profiling in Brodmann's Area 46 from subjects with schizophrenia. Aust. N. Z. J. Psychiatry. 2007;41:308–320
  13. Ditlevsen DK, Povlsen GK, Berezin V, Bock E. NCAM-induced intracellular signaling revisited. J. Neurosci. Res. 2008;86:727–743
  14. Dorph-Petersen KA, Pierri JN, Wu Q, Sampson AR, Lewis DA. Primary visual cortex volume and total neuron number are reduced in schizophrenia. J. Comp. Neurol. 2007;501:290–301
  15. Doyle E, Nolan PM, Bell R, Regan CM. Hippocampal NCAM180 transiently increases sialylation during the acquisition and consolidation of a passive avoidance response in the adult rat. J. Neurosci. Res. 1992;31:513–523
  16. Drummer OH. Postmortem toxicology of drugs of abuse. Forensic Sci. Int. 2004;142:101–113
  17. Frost G, Patel K, Bourne S, Coakham HB, Kemshead JT. Expression of alternative isoforms of the neural cell-adhesion molecule (NCAM) on normal brain and a variety of brain-tumors. Neuropathol. Appl. Neurobiol. 1991;17:207–217
  18. Fux CM, Krug M, Dityatev A, Schuster T, Schachner M. NCAM180 and glutamate receptor subtypes in potentiated spine synapses: an immunogold electron microscopic study. Mol. Cell. Neurosci. 2003;24:939–950
  19. Gilbert SJ, Spengler S, Simons JS, Steele JD, Lawrie SM, Frith CD, et al. Functional specialization within rostral prefrontal cortex (area 10): a meta-analysis. J. Cogn. Neurosci. 2006;18:932–948
  20. Gliner JA, Morgan GA, Harmon RJ. Basic associated designs: analysis and interpretation. J. Am. Acad. Child Adolesc. Psychiatry. 2002;41:1256–1258
  21. He HT, Barbet J, Chaix JC, Goridis C. Phosphatidylinositol is involved in the membrane attachment of NCAM-120, the smallest component of the neural cell-adhesion molecule. EMBO J. 1986;5:2489–2494
  22. Honer WG, Falkai P, Young C, Wang T, Xie J, Bonner J, et al. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neurosci. 1997;78:99–110
  23. Keefe RSE, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch. Gen. Psychiatry. 2007;64:633–647
  24. Keks N, Hill C, Opeskin K, Copolov DL, Dean B. Psychiatric diagnosis after death: the problems of accurate diagnosis. In:  Dean B,  Hyde TM,  Klienman JE editor. Using CNS Tissue in Psychiatry Research: a Practical Guide. Sydney: J. Gordon & Breach Science Publishers; 1999;p. 19–37
  25. Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ, et al. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res. Mol. Brain Res. 1995;28:311–318
  26. Leshchyns'ka I, Sytnyk V, Morrow JS, Schachner M. Neural Cell Adhesion Molecule (NCAM) association with PKC beta(2) via beta I spectrin is implicated in NCAM-mediated neurite outgrowth. J. Cell Biol. 2003;161:625–639
  27. Levy R, Goldman-Rakic PS. Association of storage and processing functions in the dorsolateral prefrontal cortex of the nonhuman primate. J. Neurosci. 1999;19:5149–5158
  28. Lyons F, Martin ML, Maguire C, Jackson A, Regan CM, Shelley RK. The expression of an N-CAM serum fragment is positively correlated with severity of negative features in type-II schizophrenia. Biol. Psychiatry. 1988;23:769–775
  29. MacDonald AW, Carter CS, Kerns JG, Ursu S, Barch DM, Holmes AJ, et al. Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. Am. J. Psychiatry. 2005;162:475–484
  30. Mackowiak M, Dudys D, Chocyk A, Wedzony K. Repeated risperidone treatment increases the expression of NCAM and PSA-NCAM protein in the rat medial prefrontal cortex. Eur. Neuropsychopharmacol. 2009;19:125–137
  31. McCarthy G, Blamire AM, Puce A, Nobre AC, Bloch G, Hyder F, et al. Functional magnetic resonance imaging of human prefrontal cortex activation during a spatial working memory task. Proc. Natl. Acad. Sci. U. S. A. 1994;91:8690–8694
  32. Narayan S, Tang B, Head SR, Gilmartin TJ, Sutcliffe JG, Dean B, et al. Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res. 2008;1239:235–248
  33. Nybroe O, Linnemann D, Bock E. Heterogeneity of soluble neural cell-adhesion molecule. J. Neurochem. 1989;53:1372–1378
  34. Parnas J. From predisposition to psychosis: progression of symptoms in schizophrenia. ACTA Psychiatr. Scand. 1999;99:20–29
  35. Perlstein WM, Carter CS, Noll DC, Cohen JD. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am. J. Psychiatry. 2001;158:1105–1113
  36. Pollerberg GE, Schachner M, Davoust J. Differentiation state-dependent surface mobilities of 2 forms of the neural cell-adhesion molecule. Nature. 1986;324:462–465
  37. Pollerberg GE, Burridge K, Krebs KE, Goodman SR, Schachner M. The 180-kD component of the neural cell-adhesion molecule N-CAM is involved in cell–cell contacts and cytoskeleton–membrane interactions. Cell Tissue Res. 1987;250:227–236
  38. Poltorak M, Khoja I, Hemperly JJ, Williams JR, El-Mallakh R, Freed WJ. Disturbances in cell recognition molecules (N-CAM and Ll antigen) in the CSF of patients with schizophrenia. Exp. Neurol. 1995;131:266–272
  39. Santoni MJ, Barthels D, Vooper G, Boned A, Gordis C, Wille W. Differential exon usage involving an unusual splicing mechanism generates at least eight types of NCAM cDNA in mouse brain. EMBO J. 1989;8:385–392
  40. Schuster T, Krug M, Hassan H, Schachner M. Increase in proportion of hippocampal spine synapses expressing neural cell adhesion molecule NCAM180 following long-term potentiation. J. Neurobiol. 1998;37:359–372
  41. Sullivan PF, Keefe RSE, Lange LA, Lange EM, Stroup TS, Lieberman J, et al. NCAM1 and neurocognition in schizophrenia. Biol. Psychiatry. 2007;61:902–910
  42. Tanaka Y, Yoshida S, Shimada Y, Ueda H, Asai K. Alteration in serum neural cell adhesion molecule in patients of schizophrenia. Hum. Psychopharmacol. Clin. Exp. 2007;22:97–102
  43. Tao R, Li C, Zheng YL, Qin W, Zhang J, Li XW, et al. Positive association between SIAT8B and schizophrenia in the Chinese Han population. Schizophr. Res. 2007;90:108–114
  44. Theodosis DT, Bonhomme R, Vitiello S, Rougon G, Poulain DA. Cell surface expression of polysialic acid on NCAM is a prerequisite for activity-dependent morphological neuronal and glial plasticity. J. Neurosci. 1999;19:10228–10236
  45. Uryu K, Butler AK, Chesselet MF. Synaptogenesis and ultrastructural localization of the polysialylated neural cell adhesion molecule in the developing striatum. J. Comp. Neurol. 1999;405:216–232
  46. van Kammen DP, Poltorak M, Kelley ME, Yao JK, Gurklis JA, Peters JL, et al. Further studies of elevated cerebrospinal fluid neuronal cell adhesion molecule in schizophrenia. Biol. Psychiatry. 1998;43:680–686
  47. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:research0034
  48. Vawter MP, Cannon-Spoor HE, Hemperly JJ, Hyde TM, VanderPutten DM, Kleinman JE, et al. Abnormal expression of cell recognition molecules in schizophrenia. Exp. Neurol. 1998;149:424–432
  49. Vawter MP, Usen N, Thatcher L, Ladenheim B, Zhang P, VanderPutten DM, et al. Characterization of human cleaved N-CAM and association with schizophrenia. Exp. Neurol. 2001;172:29–46
  50. Wood GK, Tomasiewicz H, Rutishauser U, Magnuson T, Quirion R, Rochford J, et al. NCAM-180 knockout mice display increased lateral ventricle size and reduced prepulse inhibition of startle. Neuroreport. 1998;9:461–466
  51. Yoon JH, Minzenberg MJ, Ursu S, Walters R, Wendelken C, Ragland JD, et al. Association of dorsolateral prefrontal cortex dysfunction with disrupted coordinated brain activity in schizophrenia: Relationship with impaired cognition, behavioral disorganization, and global function. Am. J. Psychiatry. 2008;165:1006–1014

PII: S0920-9964(09)00164-9

doi: 10.1016/j.schres.2009.04.002

Schizophrenia Research
Volume 112, Issue 1 , Pages 65-71 , July 2009

Article Tools

* Image Usage & Resolution